Amanta Healthcare (NSE:AMANTA) Stock Based Compensation: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AMANTA Amanta Healthcare Ltd NSE:AMANTA
15 GF Score
Price ₹186.51
! 7 Warning Signs
View Full Analysis

What is Amanta Healthcare Stock Based Compensation?

Amanta Healthcare NSE:AMANTA +5.00% 15 Stock Based Compensation is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AMANTA with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Amanta Healthcare's Stock Based Compensation for the three months ended in Jun. 2026 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil.

Amanta Healthcare Stock Based Compensation Related Terms

Amanta Healthcare Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Amanta Healthcare's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amanta Healthcare Stock Based Compensation Chart

Amanta Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
0.00 0.00 0.00 0.00 0.00

Amanta Healthcare Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:AMANTA
15GF Score
Amanta Healthcare Ltd NSE:AMANTA
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amanta Healthcare Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

What does a Stock Based Compensation of ₹0 Mil mean?
Amanta Healthcare (NSE:AMANTA) has a Stock Based Compensation of ₹0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Amanta Healthcare and its competitors.
Is Amanta Healthcare's Stock Based Compensation too high?
Amanta Healthcare's current Stock Based Compensation is ₹0 Mil. Overall, Amanta Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's Stock Based Compensation compare to ZTS?
Amanta Healthcare's Stock Based Compensation of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Amanta Healthcare and its competitors. Amanta Healthcare's current Stock Based Compensation is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current Stock Based Compensation of ₹0 Mil. The current Stock Based Compensation is ₹0 Mil. Amanta Healthcare's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current Stock Based Compensation is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amanta Healthcare Business Description

Other Exchanges 544502:India
Address C.J. Marg, 8th Floor, Shaligram Corporates, Ambli, Ahmedabad, GJ, IND, 380058
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
15GF Score

Get the complete analysis for NSE:AMANTA

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹186.51
Price